Masimo shares rocketed after biotech conglomerate Danaher struck a deal to acquire the medical-device maker for almost $10 ...

General Mills is getting aboard the GLP-1 train as it navigates shaky consumer sentiment. Chief Executive Jeff Harmening told investors Tuesday that the weight-loss drugs will have a lasting influence ...

Activist Elliott Investment Management has built a more than 10% stake in the cruise-ship operator and plans to push for changes to turn it around, [The Wall Street Journal reported]( ...

After details of payments from Beijing’s sports bureau to freestyle skiing champion Eileen Gu were accidentally revealed last ...

Warner Bros. Discovery said it would restart deal talks with Paramount Skydance—setting the stage for a potential bidding war between Paramount and preferred bidder Netflix. Shares of Paramoun ...

The owner of NAPA auto-care centers plans to separate its auto-parts business from its industrial-parts unit into two separate public companies, [WSJ reported]( ...

The conglomerate’s investment would be a boost to the country’s ambitions to become a global leader in artificial intelligence.

Patients on the higher dose of 7.2 milligrams for about 18 months lost 21% of their body weight on average, a study found.

That's the amount Micron Technology is spending to expand its U.S. manufacturing. The memory-chip maker is racing to avert ...

Walmart's earnings will headline corporate reports in this holiday-shortened week. There will also be a batch of economic data ...

Guides who escorted Chinese tourists through the museum allegedly reused tickets and bribed security to look the other way.

General Mills lowered its sales and profit outlook for the fiscal year, as stressed consumers are buying fewer snacks and looking for more promotions.